Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -35.262% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) Cc1nn(C)c(C(=O)NNC(=S)NCC(C)C)c1Cl
b) Cc1ccc(CNC(=O)CCn2nc(-c3ccc(Cl)cc3)ccc2=O)cc1
c) Cn1c(SCC(=O)Nc2sc3c(c2C#N)CCC3)nnc1C1COc2ccccc2O1
d) Fc1ccc(CNc2ccc(N3CCN(Cc4ccccc4)CC3)cc2)cc1
e) OCC1(Cc2ccccc2)CCCN(Cc2c[nH]c3ccccc23)C1
Answer: b. Cc1ccc(CNC(=O)CCn2nc(-c3ccc(Cl)cc3)ccc2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(CNC(=O)CCn2nc(-c3ccc(Cl)cc3)ccc2=O)cc1
Cc1ccc(CNC(=O)CCn2nc(-c3ccc(Cl)cc3)ccc2=O)cc1
3-[3-(4-chlorophenyl)-6-oxopyridazin-1-yl]-N-[(4-methylphenyl)methyl]propanamide